WeSearch

Tuesday briefing: Palantir’s rise – and why so many oppose its role in the British state

https://www.theguardian.com/profile/patrick-greenfield· ·10 min read · 0 reactions · 0 comments · 16 views
#technology#politics#defense#healthcare#ethics#Palantir Technologies#John Healey#Alex Karp#Peter Thiel#NHS
Tuesday briefing: Palantir’s rise – and why so many oppose its role in the British state
⚡ TL;DR · AI summary

Palantir Technologies has rapidly expanded its influence, particularly in the UK, where its software is utilized across various sectors including health and defense. The company's controversial practices and partnerships have sparked significant criticism, raising questions about its power and ethical implications. Founded by Peter Thiel, Palantir's growth has been marked by a contentious reputation, especially following recent statements from its CEO.

Key facts
Original article
the Guardian · https://www.theguardian.com/profile/patrick-greenfield
Read full at the Guardian →
Opening excerpt (first ~120 words) tap to expand

UK defence secretary John Healey, left, and Palantir CEO Alex Karp sign a £1.5bn investment partnership last September. Photograph: Lucy North/PAView image in fullscreenUK defence secretary John Healey, left, and Palantir CEO Alex Karp sign a £1.5bn investment partnership last September. Photograph: Lucy North/PAFirst Edition newsletterPalantirTuesday briefing: Palantir’s rise – and why so many oppose its role in the British stateIn today’s newsletter: Its software is used from health services to militaries. But controversies and criticism of the $375bn company are leading some to ask if Palantir is too powerfulPatrick GreenfieldTue 2 Jun 2026 01.46 EDTLast modified on Tue 2 Jun 2026 01.47 EDTSharePrefer the Guardian on GoogleGood morning. The Peter Mandelson story keeps unfolding.

Excerpt limited to ~120 words for fair-use compliance. The full article is at the Guardian.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from the Guardian